BrainStorm Cell Therapeutics Inc. Enters into Collaborative Agreement with Hadassah-Hebrew University to Conduct Clinical Trials

Published: Feb 22, 2010

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, is extremely pleased to announce that it has entered into a collaborative agreement with Hadassah Medical Center to conduct its ALS clinical trials at the Hadassah Ein Kerem Hospital.

Back to news